Avian Influenza Virus (AIV) is a member of the Orthomyxoviridae family that primarily infects birds. This virus can causeacute respiratory diseases in avian species, and severe cases often result in high mortality rates. AIV is categorized intosubtypes based on two surface proteins, namely hemagglutinin (H, such as H5, H7, H9) and neuraminidase (N, such asN1, N2). The H9 subtype of AIV (primarily H9N2 subtype), classified as low pathogenic avian influenza, has become endemic in poultry populations across Asia, the Middle East, and Africa. While typically causing mild respiratory signs and reduced egg production in birds, H9N2 poses significant concerns due to its dual role as both a frequent gene donor for dangerous reassortant viruses (contributing internal genes to H5N1, H7N9 and other subtypes) and its demonstratedzoonotic potential. Therefore, rapid and accurate diagnosis of H9 is crucial . The Avian Influenza Virus H9 Subtype Nucleic Acid Detection Kit developed by SunshinyMed assists in the diagnosis of AIV H9 Subtype and public health management.

The SunshinyMed Avian Influenza Virus H9 Subtype Nucleic Acid Detection Kit uses the Reverse Transcription Quantitative Real-Time Polymerase Chain Reaction (RT-qPCR) method to qualitatively detect AIV-H9 RNA in specimens such as avian tissues, secretions, excreta, and chicken embryo allantoic fluid, providing a reliable basis for clinical disease diagnosis.

Product Parameters

Materials provided

50 sets of PCR amplification freeze-dried reagents

50 sets of nucleic acid extraction reagents

50 sampling swabs

50 vials of sample preservation solution